HTRA2 / Serine protease HTRA2, mitochondrial · Western blot design guide

Design a Western Blot for HTRA2

Real validated HTRA2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-HTRA2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for HTRA2: expected band ~48.8 kDa, hero antibody A01941-3, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable HTRA2 Western blot protocol sheet — expected band ~48.8 kDa, antibody A01941-3, controls and PMC citations. Open the full HTRA2 WB guide →

HTRA2 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~48.8 kDa
Observed band ~36 kDa
Gel 5–20% (catalog A01941-3)
Positive control ⓘ Adrenal gland (IHC candidate; verify WB) +4 more
Negative control ⓘ Heart muscle (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM Ubl conjugation + Cleaved
Caveat Mature versus precursor
Gene-set association MSigDB Hallmark membership
Isoform 4 isoform(s)
Section 1

Real Curated HTRA2 Western Blot Protocols

The A01941-3 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatehuman 293T, human HT-1080, human Hela (catalog A01941-3)
Gel %5–20% (catalog A01941-3)
Load30 ug; reducing conditions (catalog A01941-3)
Transfera nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A01941-3)
Membranenitrocellulose membrane (catalog A01941-3)
Blocking5% non-fat milk/TBS for 1.5 hour at RT (catalog A01941-3)
Primary antibodyA01941-3 · 0.5 μg/mL (catalog A01941-3)
Primary incubationovernight at 4°C (catalog A01941-3)
Secondary antibodygoat anti-rabbit IgG-HRP, 1:5000 (catalog A01941-3)
Secondary incubation1.5 hour at RT (catalog A01941-3)
WashTBS-0.1%Tween 3 times with 5 minutes each (catalog A01941-3)
DetectionECL (catalog A01941-3)
Section 2

What Is the Expected HTRA2 Western Blot Band Size?

HTRA2 is predicted at 48.8 kDa and observed near 36 kDa; the cause of the difference is not established.

What am I looking at on my blot?
Band near 36 kDaEmpirical HTRA2 band in reducing whole-cell blots; confirm identity with appropriate controls
Band near 48.8 kDaPossible full-length precursor near the UniProt predicted mass
Band below the precursorPropeptide cleavage could yield a smaller mature protein
Several bands at different positionsIsoforms 1, 2, 3 and 4 or processing could contribute; distinct bands are not established
💡Expected HTRA2 appearanceUniProt predicts a 48.8 kDa precursor, while antibody QC shows an HTRA2 band near 36 kDa in reducing whole-cell lysates; the cause of the difference needs band-identity controls.
How each factor affects band size
UniProt predicted precursor massPredicts 48.8 kDa; the empirical HTRA2 band is near 36 kDa
Propeptide residues 32..133Cleavage can make mature HTRA2 smaller than its precursor; its observed migration is not established by this feature alone
Splice isoform 1May differ in size from the other named isoforms; its mass is not supplied
Splice isoforms 2, 3 and 4May differ in size from isoform 1 or each other; their masses are not supplied
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateMitochondrial HTRA2 may be poorly recoveredCheck mitochondrial enrichment and a positive-control lysate
Band higher than expectedFull-length precursor may remain alongside the band near 36 kDaCompare precursor and mature forms with a validated HTRA2 control
Band lower than expectedPropeptide processing could produce a smaller formCompare with the band near 36 kDa and confirm identity by HTRA2 depletion
Multiple bandsAlternative splicing or processing may contributeUse HTRA2 depletion and isoform-specific controls where available
Weak or no signalMitochondrial recovery or HTRA2 abundance may be lowCheck loading, mitochondrial recovery and a positive control
Fragments below expected sizeHTRA2 has an autocatalytic cleavage annotation; sample degradation is also possibleUse fresh lysate with protease inhibitors and confirm fragments by HTRA2 depletion

Sample controls for HTRA2 Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for HTRA2 in Western blot, you can use adrenal gland lysate, based on its HPA medium expression.
Positive control: Adrenal gland (IHC candidate; verify WB)
Negative control: Heart muscle (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain such as Ponceau alongside the samples.
⚠️Feasibility: HTRA2 is mitochondrial, so a mitochondrial-enriched fraction may improve detection.

HPA tissue expression evidence for HTRA2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Adrenal gland glandular cells Medium Protein (IHC) HPA →
Appendix glandular cells Medium Protein (IHC) HPA →
Bone marrow hematopoietic cells Medium Protein (IHC) HPA →
Breast glandular cells Medium Protein (IHC) HPA →
Bronchus respiratory epithelial cells Medium Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Heart muscle cardiomyocytes Not detected Protein (IHC) HPA →
Ovary ovarian stroma cells Not detected Protein (IHC) HPA →
Skeletal muscle myocytes Not detected Protein (IHC) HPA →
Spleen cells in red pulp Not detected Protein (IHC) HPA →
Adipose tissue adipocytes Low Protein (IHC) HPA →
Section 3

Advanced HTRA2 Western Blot Tips

Deeper troubleshooting and optimisation questions for HTRA2, answered from its protein features.

How should HTRA2 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could HTRA2 isoforms produce different bands?
Isoforms · Yes. Four isoforms are listed. Relative to the canonical sequence, isoform 2 lacks residues 238..302 and 372..403; isoform 3 changes residue 313 and lacks 372..403; isoform 4 replaces residues 314..458. These are UniProt coordinates. Check whether the antibody's epitope is retained before assigning a band to an isoform.
Can a modification explain an unexpected HTRA2 band?
PTM · The supplied features list no modified residue or glycosylation site, although the keywords include Ubl conjugation. They do not identify a modification that explains a particular band shift. Check processing and the listed isoform sequences before attributing an unexpected band to modification.
Does this guide establish induction of HTRA2?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for HTRA2?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A01941-3 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
What should be controlled when quantifying HTRA2 bands?
Quantitation · Keep sample fraction and band assignment consistent across lanes. HTRA2 occurs predominantly in the mitochondrial intermembrane space, can move to the cytosol after apoptotic stimuli, and has four listed isoforms. Quantifying a single band without resolving these possibilities may mix changes in abundance with changes in localization or isoform detection.
Why might HTRA2 appear near 36 kDa instead of 48.8 kDa?
Interpretation · 48.8 kDa is the predicted mass of the full-length protein. UniProt lists a propeptide at residues 32..133, so processing could contribute to a smaller band. The supplied observations place a band near 36 kDa, but the feature alone does not establish that band's identity or exact cleavage site.

The canonical sequence is 458 residues, and UniProt marks residues 32..133 as a propeptide. Compare bands with the predicted full-length mass of 48.8 kDa and the observed band near 36 kDa, while treating either assignment as provisional until validated experimentally.

HTRA2 is predominantly in the mitochondrial intermembrane space and can be released into the cytosol after apoptotic stimuli such as UV treatment. When comparing conditions, measure the same fraction each time; a change in cytosolic signal may reflect redistribution rather than a change in total HTRA2.

Consider the listed propeptide at UniProt residues 32..133, autocatalytic cleavage keyword, and isoform sequence changes when evaluating additional bands. None alone identifies a band. Confirm an assignment with an antibody whose epitope is present in the proposed sequence and compare the expected sample fractions.
Boster reagents

HTRA2 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of HTRA2 using anti-HTRA2 antibody (A01941-3). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human 293T whole cell lysates, Lane 2: human HT-1080 whole cell lysates, Lane 3: human Hela whole cell lysates, Lane 4: human HEL whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-HTRA2 antigen affinity purified polyclonal antibody (Catalog # A01941-3) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for HTRA2 at approximately 36 kDa. The expected band size for HTRA2 is at 36,49 kDa.
Anti-HTRA2 Antibody Picoband®
Cat # A01941-3
Real WB data Western blot analysis of HTRA2 expression in Jurkat cell lysate.
Anti-HTRA2/Omi Rabbit Monoclonal Antibody
Cat # M01941
Real WB data Western blot analysis of OMI in U937 lysate with Omi antibody at (A) 0.5, (B) 1, and (C) 2 μg/mL.
Anti-OMI HTRA2 Antibody
Cat # A01941

Three the supplier anti-HTRA2 antibodies have WB images using human cell lysates. A01941-3 reports a band near 36 kDa across four human cell lines; M01941 shows Jurkat lysate, and A01941 shows U937 lysate. The supplied images do not demonstrate mouse or rat samples.

Which to pick: For human lysates, A01941-3 has the most detailed reported WB conditions; A01941 provides U937 data at three antibody concentrations. M01941 lists human, mouse, and rat reactivity, but its supplied WB image uses human Jurkat lysate. All three have WB images.

Source: BosterBio HTRA2 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.